rituximab SC
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for rituximab SC, covering 2022-08-25 to 2022-08-25. Get the full timeline:
Most recent: Clinical Trial Update: Risk-stratified Sequential Treatment of Post-transplant Lymphoproliferative Disease (PTLD) With Rituximab SC and Immunochemotherapy [Phase 2]